DEXWireNews

DEXWireNews

THE CURRENT AVERAGE ANALYSTS PRICE TARGET IS $11.72 WHILE THE STOCK PRICE IS $11.40, THUS ANALYSTS WILL EITHER HAVE TO RAISE OR LOWER, WE ARE OF THE OPINION THAT IT WILL BE A RAISE. NYSE:SNAP HAS ALWAYS CARRIED SPECULATION BUT CURRENT SPECULATION REGARDING THE INTRODUCTION OF MUSIC WOULD BE HUGELY IMPORTANT MOVE FOR SNAP. CONSIDERING THE CORE CUSTOMERS ARE...

DEXWireNews

Pivotal Research today initiated NYSE:TWTR with a Buy rating and a $48 price target. Twitter should be a real winner in the current environment, given the fact there is a election approaching and it has now become the Media channel of choice for MR Trump, with others likely to use it as a similar platform for their campaigns. TWTR has also no reliance on China...

DEXWireNews

When options traders make a big bet, it always makes a stock interesting as they are often in the know, recent $30 call option volume has been unusually high in the past few days in NYSE:SIG . Which also makes the stock a possibility for a reversal pop is the high short volume and the fact it may have found some support on 2003 and 2009 levels, YIP that's how bad...

DEXWireNews

The most recent earnings report blow through estimates, sales in quarter jumped 47% and $5 million above estimates, taking the company closer to profitability, with a loss per share of $.16 which exceeded the $.20 estimate. due to a increase in current client spending the company has raised its guidance once again. This is a high growth sector and under the...

DEXWireNews

Unfortunately NYSE:YEXT will release earnings in the middle of a sell off, but we are confident that earnings will surprise to the upside, the stock gains will probably be hampered by market sentiment. Yext has become more appealing to the analysts community, SunTrust analysts Naved Khan yesterday reiterated a Buy rating and a $30 target, he wrote “We expect...

DEXWireNews

TransEnterix, Inc. TRXC, +4.13% a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has received Japanese regulatory approval for the Senhance™ Surgical System. “Regulatory approval in Japan is a pivotal milestone for our company, as Japan is second only to the U.S....

DEXWireNews

*****************armata-pharmaceuticals-announces-publication-of-successful-adjunctive-phage-treatment-in-cystic-fibrosis-patient************** Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based...

DEXWireNews

***** On the watch-list for possible breakout today after unusual volume at the end of last week for no apparent reason. Possibly some sort of announcement is on the schedule for this week, it has caught the attention of many speculators on social media and forums etc, so any move will be frantic. COMPANY PROFILE Nobilis Health Corp. engages in the operation...

DEXWireNews

It is so appealing to go for a long entry in OTC:CWBHF pre earnings, because it has been beaten down quite badly, but there may be just more downside and a better entry point. The technical indicators are all heading south and sell side volume continues to be high. If it were to drop out of the golden pocket below $14 it is a short to $8. AVERAGE ANALYSTS PRICE...

DEXWireNews

Upgrades galore for NASDAQ:PIRS lately as analysts see great upside potential for the company. Most recently PIRS presented data from a phase 1 study on its new technology ANTICALIN which it is developing in collaboration with NYSE:AZN was released and commented on by the Chief development officer. "We are encouraged by the safety and tolerability of...

DEXWireNews

IT HAS ALREADY BEEN A EVENTFUL WEEK FOR NASDAQ:TNXP WITH CAPITAL RAISE ISSUES AND A NEW PIPELINE DRUG CANDIDATE UPDATE. NEST WEEK COULD BE EQUALLY IMPORTANT AS ON TUESDAY THE COMPANY RELEASES DATA ON TNX-102 PHARMACOKINTEC . THE STOCK IS SETTING UP NICELY FOR THE WEEK TO COME. COMPANY PROFILE Tonix Pharmaceuticals Holding Corp. is a clinical-stage...

DEXWireNews

In recent analysis by J Mintzmer he makes come very positive points regarding NYSE:STNG he wrote "Scorpio Tankers (STNG) has the world's largest fleet of modern product tankers. With major fuel regulations pending in 2020, product markets are poised to surge.Scorpio Tankers (NYSE:STNG) is a product tanker pure-play with the world's largest publicly-traded fleet...

DEXWireNews

United Continental Airlines yesterday was the Knight in shinning Armour for investors in NYSE:AVH as the battle commences to keep their planes in the air. They company is crippled with debt has a very limited fleet of old planes after leasing companies took repossession after repayments were defaulted upon. UCA will now loan the company money and build its own...

DEXWireNews

Revolution Lighting Technologies stated Friday that on May 22, 2019, the Company received a letter from the Nasdaq Hearings Panel of The Nasdaq Stock Market informing the Company that the Panel has granted the Company’s request to stay the suspension of the Company’s securities from Nasdaq pending a final determination from the Panel regarding the Company’s...

DEXWireNews

Heightened tension between China and the USA have had a massive impact on the stock of NYSE:NIO but that is not the only reason. The stock finds itself at a all time low after producing very poor earnings in the previous quarter and that is unlikely to change. Competition within the sector is also mounting as the displacement away from gas intensifies, which...

DEXWireNews

Difficult to build a case for this as it is purely speculation and rumor that has highlighted the stock of NASDAQ:CLVS . There has been some option activity which is encouraging and positive trial data which failed to rally the stock. The contrarian long option is going against strong negatives such as, high debt, decreasing pricing power, insider selling and...

DEXWireNews

It has become a real "I'm the biggest Bear" among the Analysts community to get a ridiculously low downgrade onto the CNBC Merry go round. Today may be the final day for the Bears to party, Gene Munster today was less than complementary regarding TSLA's future under Musk, he is a highly regarded analyst and his opinion counts. The fact he did not make a silly...

DEXWireNews

*********alert ******* NASDAQ:SANW STOCK HAS BEEN Halted this morning on unusual volume and news pending within conference call at 11.00 ET . Stock had gaped up 24% before been halted, strong watch for today ANALYSTS PRICE TARGET $4.83 ANALYSTS RECOMMENDATION BUY COMPANY PROFILE S&W Seed Co. is an agricultural company, which engages in the production and...